Procarta Biosystems
PrivateLast Round
Grant
Sep 19, 2019
Total Funding Raised
$9.2M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Procarta Biosystems operates in Healthcare & Life Sciences and is based in Norwich. Its latest recorded funding round was a Grant round in September 2019.
Procarta Biosystems is a biotechnology company that develops oligonucleotide-based antimicrobial agents to combat drug-resistant bacterial infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Procarta Biosystems Comparables
Compare Procarta Biosystems with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nemesis Bioscience | 78% | |
| Locus Biosciences | 77% | |
| smartbax GmbH | 76% |
For institutional investors. Book with your work email.
Procarta Biosystems Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 19, 2019 | ||||
| VC Round | Mar 5, 2019 |
For institutional investors. Book with your work email.
Procarta Biosystems Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CARB-X | Grant |
| Meltwind Advisory | VC Round |
| Novo Holdings | VC Round |
| UK Innovation & Science Seed Fund | VC Round |
| Morningside Group | VC Round |
| Wren Capital | VC Round |
| Development Bank of Wales | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 320% MoM.
- Sep 19, 2019
$9.2M grant received from CARB-X
For institutional investors. Book with your work email.
Procarta Biosystems Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Procarta Biosystems's valuation, stock price, and market status.
Is Procarta Biosystems a public or private company?
Procarta Biosystems is a private company.
What is the current stock price of Procarta Biosystems?
Procarta Biosystems is a private company, so its shares have no public market price. Caplight tracks Procarta Biosystems's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Procarta Biosystems worth (valuation)?
Valuation information for Procarta Biosystems is not publicly available.
Can I buy Procarta Biosystems stock?
Procarta Biosystems shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Procarta Biosystems's last funding round?
Procarta Biosystems's most recent funding round was Grant on September 19, 2019.
Who are the main investors in Procarta Biosystems?
Key investors in Procarta Biosystems include Novo Holdings, Morningside Group.
Will Procarta Biosystems IPO soon?
No public IPO plans have been announced for Procarta Biosystems.
How can I track Procarta Biosystems secondary market activity?
Caplight tracks bids, offers, and trades in Procarta Biosystems's shares on secondary markets.